West Pharmaceutical Ownership

West Pharmaceutical Services retains a total of 72.42 Million outstanding shares. The majority of West Pharmaceutical outstanding shares are owned by institutional investors. These institutions are usually referred to as non-private investors looking to purchase positions in West Pharmaceutical to benefit from reduced commissions. Consequently, other corporate entities are subject to a different set of regulations than regular investors in West Pharmaceutical Services. Please pay attention to any change in the institutional holdings of West Pharmaceutical as this could imply that something significant has changed or is about to change at the company. Please note that on August 21, 2024, Representative Jared Moskowitz of US Congress acquired under $15k worth of West Pharmaceutical's common stock. Some institutional investors establish a significant position in stocks such as West Pharmaceutical in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of West Pharmaceutical, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits. Dividends Paid is likely to gain to about 59.9 M in 2024, whereas Dividend Yield is likely to drop 0 in 2024. Net Income Applicable To Common Shares is likely to gain to about 707.5 M in 2024, whereas Common Stock Shares Outstanding is likely to drop slightly above 74.7 M in 2024. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in West Pharmaceutical Services. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.